---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-018231"
form_type: "8-K"
ticker: "FRMM"
cik: "0001690080"
company_name: "FORUM MARKETS Inc"
filed_at: "2024-02-29T23:59:59+00:00"
generated_at: "2026-06-05T06:54:23.036445+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# 180 Life Sciences appoints Blair Jordan as independent director; compensation includes deferred cash fees

## Summary
- Blair Jordan appointed as Class II director effective Feb 28, 2024; serves as Lead Independent Director and Chair of Strategy & Alternatives Committee.
- Annual cash compensation: $40K retainer + $10K committee chair + $15K lead director; initial payment $7,500.
- Half of cash compensation accrued until company raises $1M aggregate from any source.
- Jordan is independent under Nasdaq rules; serves on Audit, Compensation, Nominating and Governance, and Risk committees.
- Jordan previously served as interim CEO/CFO of Ascent Industries, which obtained creditor protection under CCAA.

## SEC filing metadata
- accession: 0001213900-24-018231
- form_type: 8-K
- ticker: FRMM
- cik: 0001690080
- company_name: FORUM MARKETS Inc
- filed_at: 2024-02-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690080/000121390024018231/0001213900-24-018231-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690080/000121390024018231/ea0200917-8k_180life.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-018231
- JSON: https://secwatch.observer/filing/0001213900-24-018231.json
- Plain text: https://secwatch.observer/filing/0001213900-24-018231.txt

## Key facts
- Executive change
  Blair Jordan was appointed as Director at FORUM MARKETS Inc.
  - Action: appointed
  - Role: Director
  source text: February 28, 2024, the Board of Directors of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”), appointed Blair Jordan as a member of the Board of Directors (“ Board ”), to fill one of the vacancies on the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390024018231/0001213900-24-018231-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.